Harrow, Inc. (HROW)
36.00
-0.35
(-0.96%)
USD |
NASDAQ |
Mar 26, 09:40
Harrow Free Cash Flow : 42.76M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Corcept Therapeutics, Inc. | 141.78M |
| Esperion Therapeutics, Inc. | -13.09M |
| Regeneron Pharmaceuticals, Inc. | 3.765B |
| Theravance Biopharma, Inc. | 238.50M |
| Rhythm Pharmaceuticals, Inc. | -156.63M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 8.411M |
| Cash from Investing (Quarterly) | -4.73M |
| Cash from Financing (Quarterly) | -5.044M |
| Free Cash Flow Per Share (Quarterly) | 0.2159 |
| Free Cash Flow to Equity (Quarterly) | 7.935M |
| Free Cash Flow to Firm (Quarterly) | 11.34M |
| Free Cash Flow Yield | 3.15% |